Search

everythinglearnresearchcommunity

for

Search:↓

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

Abemaciclib can cause skin, hair, and nail problems, leading some patients to stop using it.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

Minoxidil and ranolazine together can reduce the spread of certain breast cancer cells.

Research from 2011 to 2020 shows androgen receptors could be key for prognosis and treatment in certain breast cancers.

Severe hair loss significantly worsens quality of life.

Low Vitamin D receptor levels in breast cancer are linked to worse outcomes and more bone metastases, and could be a marker for prognosis.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Targeted cancer therapies often cause serious skin problems that need careful management.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

The document provides advice on how to recognize and treat skin-related side effects of cancer drugs known as EGFR inhibitors.

Certain microRNAs are more common in balding areas and might be involved in male pattern baldness.

We need better ways to test and understand SARMs to make safer and more effective treatments.

Using a combination of specific cell cycle regulators is better for safely keeping hair root cells alive indefinitely compared to cancer-related methods.

Patients with advanced breast cancer and high hormone receptor levels who had surgery for ovarian/pelvic metastases lived longer, especially if they had high estrogen receptor levels.

Scalp cooling therapy helps preserve hair during chemotherapy for most patients.

Keratins help protect cells, aid in cancer diagnosis, and influence cancer behavior and treatment.

The conclusion is that using drugs to block the TOR pathway might slow aging and prevent age-related diseases.

The document concludes that the fast-growing direct-to-consumer genetic testing market lacks sufficient regulation, posing risks to consumers due to questionable test quality and accuracy.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.

Blocking the Wnt pathway could lead to new treatments for cancer and tissue repair but requires careful development to avoid side effects.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Eclipta alba has many health benefits and contains compounds with potential for drug development.

Regenerative pharmacology, which combines drugs with regenerative medicine, shows promise for repairing damaged body parts and needs more interdisciplinary research.

Researchers created hair-inducing human cell clusters using a 3D culture method.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.